PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

The 008 Update, page-7

  1. 3,799 Posts.
    lightbulb Created with Sketch. 1562
    Good stuff Moz. I get the feeling this year will be pivotal for PAR and it’s shareholders and I can see the FDA cracking on with this. I get the feeling we will get to market(or at least get a decision on us being able to go to market) earlier than we expect. My gut is telling me sometime in 2024 we will be selling iPPS to OA sufferers.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.